Biotech Breakout -XBI: Portfolio Notes and Composition Update-3
Update-3…June 25-Re-opening Paused in FLA and TX-but stocks rally anyway. NASDAQ leads up 11% YTD. Trading remains volatile e.g. VIR. Bullish trend intact for biotech IBB up 1.11%. Vaccine stocks continue strong: BNTX INO NVAX ; MRNA lagging. Diagnostic leaders today: GNMK up 10.28%, QDEL...
What’s Next for Coronavirus Stocks? Diagnostics are the Near Term Focus…Update-2
Update-2 6/20…Strong finish for biotech on Friday with XBI up 2.83% to $108.85, up 5.64% for week; and one year high. Coronavirus strong stocks for the week: GNMK HOLX NVAX RGEN TDOC VIR . Quidel (QDEL) rests at $210 handle after rocketing from $170 level on June12. GILD made a big move...
Momentum Trading Shifts to Cyclicals and Industrials but Biotech is in For the Long Run…Update-3 Steroid treatment for COVID!
Update-3 6/16/20 at opening…Futures up on 18% increase in Retail Sales and New Potential coronavirus treatment-Dexamethasone. Low dose steroid treatment is a major breakthrough and can save lives. Coronavirus stocks take a hit: GNMK INO MRNA QDEL, but XBI up 1.79%. Update at the close...
Coronavirus Stock Scoreboard May 2020…Update-3 Rotation Out of Healthcare and Biotech
June 6… see if the Rotation Trend continues through the Week of June 8 Week Ending June 6 Performance Leaders Energy, Financials, Europe. Laggards: Staples, Healthcare. IBB off 1.95%, XBI off 1%. Stocks to watch: GILD, GSK, VIR June 5…Midday trading-Rotation Rally Continues with...
What’s Next for the Biotech Bull Market? Are You a Trader or an Investor? Update-2 Sell-Off
Momentum Continues 5/29…We will update the coronavirus trade tomorrow so sign up! Today the market recovered (NAZ up 1.4%) after Trump’s rant against China. With no new news like tariffs it’s back to “don’t fight the tape, don’t fight the FED”. Its ASCO...